Article
PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine
2022-08-11
Abstract excerpt
<h4>Background: </h4> Calcitonin gene-related peptide (CGRP) antagonizing drugs represents the most important advance in migraine therapy for decades. However, these new drugs are only effective in 50–60% of patients. Recent studies have shown that the pituitary adenylate cyclase-activating peptide (PACAP38) pathway is independent from the CGRP signaling pathway. Here, we investigate PACAP38 signaling pathways in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 461371b8-a595-52d6-8307-1728eb804cf2
- DOI
- 10.21203/rs.3.rs-1922959/v1
